Anna Tesei
Anna Tesei
Verified email at
Cited by
Cited by
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained.
TA Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A
Scientific Reports, 2016
In vitro preclinical models for a rational design of chemotherapy combinations in human tumors
W Zoli, L Ricotti, A Tesei, F Barzanti, D Amadori
Critical reviews in oncology/hematology 37 (1), 69-82, 2001
p16INK4A and CDH13 hypermethylation in tumor and serum of non‐small cell lung cancer patients
P Ulivi, W Zoli, D Calistri, F Fabbri, A Tesei, M Rosetti, M Mengozzi, ...
Journal of cellular physiology 206 (3), 611-615, 2006
Role of RAF/MEK/ERK pathway, p‐STAT‐3 and Mcl‐1 in sorafenib activity in human pancreatic cancer cell lines
P Ulivi, C Arienti, D Amadori, F Fabbri, S Carloni, A Tesei, I Vannini, ...
Journal of cellular physiology 220 (1), 214-221, 2009
Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines
W Zoli, P Ulivi, A Tesei, F Fabbri, M Rosetti, R Maltoni, DC Giunchi, ...
Breast Cancer Research 7 (5), R681, 2005
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
W Zoli, L Ricotti, M Dal Susino, F Barzanti, GL Frassineti, S Folli, A Tesei, ...
British journal of cancer 81 (4), 609-615, 1999
Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells
F Fabbri, D Amadori, S Carloni, G Brigliadori, A Tesei, P Ulivi, M Rosetti, ...
Journal of cellular physiology 217 (2), 494-501, 2008
In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines
L Ricotti, A Tesei, F De Paola, P Ulivi, GL Frassineti, C Milandri, ...
Clinical cancer research 9 (2), 900-905, 2003
Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts
C Leonetti, M Scarsella, G Zupi, W Zoli, D Amadori, L Medri, F Fabbri, ...
Molecular cancer therapeutics 5 (4), 919-926, 2006
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
A Tesei, P Ulivi, F Fabbri, M Rosetti, C Leonetti, M Scarsella, G Zupi, ...
Journal of translational medicine 3 (1), 7, 2005
Isolation of stem/progenitor cells from normal lung tissue of adult humans
A Tesei, W Zoli, C Arienti, G Storci, AM Granato, G Pasquinelli, S Valente, ...
Cell proliferation 42 (3), 298-308, 2009
Activity of lipoplatin in tumor and in normal cells in vitro
C Arienti, A Tesei, A Ravaioli, M Ratta, S Carloni, S Mangianti, P Ulivi, ...
Anti-cancer drugs 19 (10), 983-990, 2008
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells
F Fabbri, G Brigliadori, P Ulivi, A Tesei, I Vannini, M Rosetti, S Bravaccini, ...
Apoptosis 10 (5), 1095-1103, 2005
Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients
P Ulivi, M Romagnoli, E Chiadini, GL Casoni, L Capelli, C Gurioli, W Zoli, ...
International journal of oncology 41 (1), 147-152, 2012
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
L Gibellini, M Pinti, F Boraldi, V Giorgio, P Bernardi, R Bartolomeo, M Nasi, ...
The FASEB Journal 28 (12), 5122-5135, 2014
Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine
I Vannini, M Bonafe, A Tesei, M Rosetti, F Fabbri, G Storci, P Ulivi, ...
Analytical Cellular Pathology 29 (4), 279-287, 2007
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells
A Tesei, W Zoli, F Fabbri, C Leonetti, M Rosetti, M Bolla, D Amadori, ...
Nitric Oxide 19 (2), 225-236, 2008
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines
M Rosetti, A Tesei, P Ulivi, F Fabbri, I Vannini, G Brigliadori, D Amadori, ...
Apoptosis 11 (8), 1321-1330, 2006
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures
D Giustarini, F Galvagni, A Tesei, A Farolfi, M Zanoni, S Pignatta, ...
Free Radical Biology and Medicine 89, 972-981, 2015
In vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines
A Tesei, L Ricotti, F De Paola, D Amadori, GL Frassineti, W Zoli
Clinical cancer research 8 (1), 233-239, 2002
The system can't perform the operation now. Try again later.
Articles 1–20